The effect of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial: a meta-analysis of the US, German, Netherlands, and Belgium sub-studies

Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries

(2010) J. G. H. van Nes et al.   BRITISH JOURNAL OF SURGERY

Regulation of adult bone turnover by sex steroids

(2010) Baruch Frenkel et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy

(2009) P. Hadji et al.   ANNALS OF ONCOLOGY

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

(2009) M. Rabaglio et al.   ANNALS OF ONCOLOGY

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

(2009) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

The effect of exemestane or tamoxifen on markers of bone turnover: Results of a German sub-study of the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial

(2009) P. Hadji et al.   BREAST

Practical guidance for the management of aromatase inhibitor-associated bone loss

(2008) P. Hadji et al.   ANNALS OF ONCOLOGY

The Effect of Tamoxifen or Exemestane on Bone Mineral Density During the First 2 Years of Adjuvant Treatment of Postmenopausal Women with Early Breast Cancer

(2008) Stephen Jones et al.   Clinical Breast Cancer

Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis

(2008) Peyman Hadji   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Menopausal symptoms and adjuvant therapy-associated adverse events

(2008) P Hadji   ENDOCRINE-RELATED CANCER

Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230

(2008) Richard Eastell et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

(2008)   LANCET ONCOLOGY

Aromatase Inhibitors: Are There Differences Between Steroidal and Nonsteroidal Aromatase Inhibitors and Do They Matter?

(2008) W. R. Miller et al.   ONCOLOGIST

Aromatase inhibitor-induced arthralgia: Clinical experience and treatment recommendations

(2007) R.E. Coleman et al.   CANCER TREATMENT REVIEWS